Table 2.
Case characteristics
| Case | Gender | Age | BMI | Vaccine type | Dose | Time from vaccination to death (days) | Time from death to autopsy (days) | Comorbidity | Grading – myocarditis (0 – 3) | Grading – epicarditis (0 – 3) | PCR analysis | Assessment of causal relationsship |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | male | 46 | 31.8 | Cormirnaty (BioNTech) | First | 0 | 7 | AH | 2 | 0 | Negative | Likely |
| 2 | female | 50 | 20 | Spikevax (Moderna) | First | 1 | 3 | - | 1 | 2 | Negativ | Likely |
| 3 | female | 62 | 22.5 | Cormirnaty (BioNTech) | First | 7 | 3 | COPD | 1 | 1 | Negative | Possible |
| 4 | male | 55 | 30.1 | Cormirnaty (BioNTech) | Second | 4 | 3 | - | 2 | 3 | Negative | Likely |
| 5 | female | 75 | 27,9 | Cormirnaty (BioNTech) | First | 1 | 9 | AH, DM, Hashimoto´s thyroiditis | 2 | 2 | HHV6 | Possible |
Abbreviations: AH arterial hypertension, COPD chronic obstructive pulmonary disease, DM diabetes mellitus